Recent data indicates that retatrutide, a innovative medication, could represent a major improvement in size reduction . This treatment combines the properties of a GLP-1 receptor and a GIP analog, potentially offering a greater outcome than available therapies . Clinical trials have demonstrated encouraging outcomes, including substantial decrease